FDA approves medication to protect babies, toddlers from RSV

Name: FDA approves medication to protect babies, toddlers from RSV
Uploaded: 2023-07-18T18:07:00-0400
Duration: 1 min 49 s
Description: The drug, nirsevimab, is one of two new options doctors hope could soon prevent the leading cause of hospitalization facing American infants. Jarred Hill reports.

The drug, nirsevimab, is one of two new options doctors hope could soon prevent the leading cause of hospitalization facing American infants. Jarred Hill reports.